메뉴 건너뛰기




Volumn 28, Issue 2, 2010, Pages 134-138

Mammalian target of rapamycin: A new target in prostate cancer

Author keywords

mTOR; Prostate cancer; Rapamycin

Indexed keywords

BICALUTAMIDE; DEFOROLIMUS; EVEROLIMUS; MAMMALIAN TARGET OF RAPAMYCIN; RAPAMYCIN; TEMSIROLIMUS;

EID: 77249092487     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2009.03.023     Document Type: Review
Times cited : (16)

References (39)
  • 1
    • 33846181370 scopus 로고    scopus 로고
    • Sunitinib vs. interferon-α in metastatic renal-cell carcinoma
    • Motzer R.J., Hutson T.E., Tomczak P., et al. Sunitinib vs. interferon-α in metastatic renal-cell carcinoma. N Engl J Med 356 (2007) 115-124
    • (2007) N Engl J Med , vol.356 , pp. 115-124
    • Motzer, R.J.1    Hutson, T.E.2    Tomczak, P.3
  • 2
    • 33846148701 scopus 로고    scopus 로고
    • Sorafenib in advanced clear-cell renal-cell carcinoma
    • Escudier B., Eisen T., Stadler W.M., et al. Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 356 (2007) 125-134
    • (2007) N Engl J Med , vol.356 , pp. 125-134
    • Escudier, B.1    Eisen, T.2    Stadler, W.M.3
  • 3
    • 0035312747 scopus 로고    scopus 로고
    • Regulation of translation initiation by FRAP/mTOR
    • Gingras A.C., Raught B., and Sonenberg N. Regulation of translation initiation by FRAP/mTOR. Genes Dev 15 (2001) 807-826
    • (2001) Genes Dev , vol.15 , pp. 807-826
    • Gingras, A.C.1    Raught, B.2    Sonenberg, N.3
  • 4
    • 0028360374 scopus 로고
    • A mammalian protein targeted by G1-arresting rapamycin-receptor complex
    • Brown E.J., Albers M.W., Shin T.B., et al. A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 369 (1994) 756-758
    • (1994) Nature , vol.369 , pp. 756-758
    • Brown, E.J.1    Albers, M.W.2    Shin, T.B.3
  • 6
    • 0037108750 scopus 로고    scopus 로고
    • Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling
    • Tee R., Fingar D.C., Manning B.D., et al. Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Proc Natl Acad Sci USA 99 (2002) 13571-13576
    • (2002) Proc Natl Acad Sci USA , vol.99 , pp. 13571-13576
    • Tee, R.1    Fingar, D.C.2    Manning, B.D.3
  • 7
    • 0036713778 scopus 로고    scopus 로고
    • TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signaling
    • Inoki K., Li Y., Zhu T., et al. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signaling. Nat Cell Biol 4 (2002) 648-657
    • (2002) Nat Cell Biol , vol.4 , pp. 648-657
    • Inoki, K.1    Li, Y.2    Zhu, T.3
  • 8
    • 0037020044 scopus 로고    scopus 로고
    • Identification of TOR signaling complexes: More TORC for the cell growth engine
    • Abraham T. Identification of TOR signaling complexes: More TORC for the cell growth engine. Cell 111 (2002) 9-12
    • (2002) Cell , vol.111 , pp. 9-12
    • Abraham, T.1
  • 9
    • 5144228549 scopus 로고    scopus 로고
    • High levels of phosphorylated form of Akt-1 in prostate cancer and non-neoplastic prostate tissues are strong predictors of biochemical recurrence
    • Ayala G., Thompson T., Yang G., et al. High levels of phosphorylated form of Akt-1 in prostate cancer and non-neoplastic prostate tissues are strong predictors of biochemical recurrence. Clin Cancer Res 10 (2004) 6572-6578
    • (2004) Clin Cancer Res , vol.10 , pp. 6572-6578
    • Ayala, G.1    Thompson, T.2    Yang, G.3
  • 10
    • 3442891477 scopus 로고    scopus 로고
    • Phosphorylation of Akt (Ser473) is an excellent predictor of poor clinical outcome in prostate cancer
    • Kreisberg J.I., Malik S.N., Prihoda T.J., et al. Phosphorylation of Akt (Ser473) is an excellent predictor of poor clinical outcome in prostate cancer. Cancer Res 64 (2004) 5232-5236
    • (2004) Cancer Res , vol.64 , pp. 5232-5236
    • Kreisberg, J.I.1    Malik, S.N.2    Prihoda, T.J.3
  • 11
    • 4344602002 scopus 로고    scopus 로고
    • The biology and clinical relevance of the PTEN tumor suppressor pathway
    • Sansal I., and Sellers W.R. The biology and clinical relevance of the PTEN tumor suppressor pathway. J Clin Oncol 22 (2004) 2954-2963
    • (2004) J Clin Oncol , vol.22 , pp. 2954-2963
    • Sansal, I.1    Sellers, W.R.2
  • 12
    • 0033957661 scopus 로고    scopus 로고
    • The PTEN tumor suppressor protein: An antagonist of phosphoinositide 3-kinase signaling
    • Vazquez F., and Sellers W.R. The PTEN tumor suppressor protein: An antagonist of phosphoinositide 3-kinase signaling. Biochim Biophys Acta 1470 (2000) M21-M35
    • (2000) Biochim Biophys Acta , vol.1470
    • Vazquez, F.1    Sellers, W.R.2
  • 13
    • 3342895823 scopus 로고    scopus 로고
    • Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton
    • Sarbassov D.D., Ali S.M., Kim D.H., et al. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol 14 (2004) 1296-1302
    • (2004) Curr Biol , vol.14 , pp. 1296-1302
    • Sarbassov, D.D.1    Ali, S.M.2    Kim, D.H.3
  • 14
    • 13844312400 scopus 로고    scopus 로고
    • Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
    • Sarbassov D.D., Guertin D.A., Ali S.M., et al. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307 (2005) 1098-1101
    • (2005) Science , vol.307 , pp. 1098-1101
    • Sarbassov, D.D.1    Guertin, D.A.2    Ali, S.M.3
  • 15
    • 0026485002 scopus 로고
    • Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
    • Shweiki D., Itin A., Soffer D., et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359 (1992) 843-845
    • (1992) Nature , vol.359 , pp. 843-845
    • Shweiki, D.1    Itin, A.2    Soffer, D.3
  • 16
    • 0036000028 scopus 로고    scopus 로고
    • Hypoxia-inducible factor-1alpha mRNA contains an internal ribosome entry site that allows efficient translation during normoxia and hypoxia
    • Lang K.J., Kappel A., and Goodall G.J. Hypoxia-inducible factor-1alpha mRNA contains an internal ribosome entry site that allows efficient translation during normoxia and hypoxia. Mol Biol Cell 13 (2002) 1792-1801
    • (2002) Mol Biol Cell , vol.13 , pp. 1792-1801
    • Lang, K.J.1    Kappel, A.2    Goodall, G.J.3
  • 17
    • 34547134517 scopus 로고    scopus 로고
    • Hypoxia-inducible factor 1α is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif
    • Land S.C., and Tee A.R. Hypoxia-inducible factor 1α is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif. J Biol Chem 282 (2007) 20534-20543
    • (2007) J Biol Chem , vol.282 , pp. 20534-20543
    • Land, S.C.1    Tee, A.R.2
  • 18
    • 0027535132 scopus 로고
    • Rapamycin-induced inhibition of p34cdc2 kinase activation is associated with G1/S-phase growth arrest in T lymphocytes
    • Morice W.G., Brunn G.J., Wiederrecht G., et al. Rapamycin-induced inhibition of p34cdc2 kinase activation is associated with G1/S-phase growth arrest in T lymphocytes. J Biol Chem 268 (1993) 3734-3738
    • (1993) J Biol Chem , vol.268 , pp. 3734-3738
    • Morice, W.G.1    Brunn, G.J.2    Wiederrecht, G.3
  • 19
    • 7944223834 scopus 로고    scopus 로고
    • Targeting the mammalian target of rapamycin (mTOR): A new approach to treating cancer
    • Chan S. Targeting the mammalian target of rapamycin (mTOR): A new approach to treating cancer. Br J Cancer 91 (2004) 1420-1424
    • (2004) Br J Cancer , vol.91 , pp. 1420-1424
    • Chan, S.1
  • 20
    • 0030021524 scopus 로고    scopus 로고
    • TOR controls translation initiation and early G1 progression in yeast
    • Barbet N.C., Schneider U., Helliwell S.B., et al. TOR controls translation initiation and early G1 progression in yeast. Mol Biol Cell 7 (1996) 25-42
    • (1996) Mol Biol Cell , vol.7 , pp. 25-42
    • Barbet, N.C.1    Schneider, U.2    Helliwell, S.B.3
  • 21
    • 0038481707 scopus 로고    scopus 로고
    • Current strategies in the management of hormone refractory prostate cancer
    • Martel C.L., Gumerlock P.H., Meyers F.J., et al. Current strategies in the management of hormone refractory prostate cancer. Cancer Treat Rev 29 (2003) 171-187
    • (2003) Cancer Treat Rev , vol.29 , pp. 171-187
    • Martel, C.L.1    Gumerlock, P.H.2    Meyers, F.J.3
  • 22
    • 0031770827 scopus 로고    scopus 로고
    • Akt-dependent and -independent survival signaling pathways utilized by insulin-like growth factor I
    • Kulik G., and Weber M.J. Akt-dependent and -independent survival signaling pathways utilized by insulin-like growth factor I. Mol Cell Biol 18 (1998) 6711-6718
    • (1998) Mol Cell Biol , vol.18 , pp. 6711-6718
    • Kulik, G.1    Weber, M.J.2
  • 23
    • 33746794674 scopus 로고    scopus 로고
    • Expression of mTOR signaling pathway markers in prostate cancer progression
    • Kremer C.L., Klein R.R., Mendelson J., et al. Expression of mTOR signaling pathway markers in prostate cancer progression. Prostate 66 (2006) 1203-1212
    • (2006) Prostate , vol.66 , pp. 1203-1212
    • Kremer, C.L.1    Klein, R.R.2    Mendelson, J.3
  • 24
    • 0034687688 scopus 로고    scopus 로고
    • Cytoplasmic-nuclear shuttling of FKBP12-rapamycin-associated protein is involved in rapamycin-sensitive signaling and translation initiation
    • Kim J.E., and Chen J. Cytoplasmic-nuclear shuttling of FKBP12-rapamycin-associated protein is involved in rapamycin-sensitive signaling and translation initiation. Proc Natl Acad Sci USA 97 (2000) 14340-14345
    • (2000) Proc Natl Acad Sci USA , vol.97 , pp. 14340-14345
    • Kim, J.E.1    Chen, J.2
  • 26
    • 16844371494 scopus 로고    scopus 로고
    • Effects of the mammalian target of rapamycin inhibitor CCI-779 used alone or with chemotherapy on human prostate cancer cells and xenografts
    • Wu L., Birle D.C., and Tannock I.F. Effects of the mammalian target of rapamycin inhibitor CCI-779 used alone or with chemotherapy on human prostate cancer cells and xenografts. Cancer Res 65 (2005) 2825-2831
    • (2005) Cancer Res , vol.65 , pp. 2825-2831
    • Wu, L.1    Birle, D.C.2    Tannock, I.F.3
  • 27
    • 58149233953 scopus 로고    scopus 로고
    • Regulation of androgen receptor transcriptional activity by rapamycin in prostate cancer cell proliferation and survival
    • Wang Y., Mikhailova M., Bose S., et al. Regulation of androgen receptor transcriptional activity by rapamycin in prostate cancer cell proliferation and survival. Oncogene 27 (2008) 7106-7117
    • (2008) Oncogene , vol.27 , pp. 7106-7117
    • Wang, Y.1    Mikhailova, M.2    Bose, S.3
  • 28
    • 33749254070 scopus 로고    scopus 로고
    • Combinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer
    • Gao H., Outang X., Banach-Petrosky W.A., et al. Combinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer. Proc Natl Acad Sci USA 103 (2006) 14477-14482
    • (2006) Proc Natl Acad Sci USA , vol.103 , pp. 14477-14482
    • Gao, H.1    Outang, X.2    Banach-Petrosky, W.A.3
  • 29
    • 0141927222 scopus 로고    scopus 로고
    • Role of PI3K/AKT/mTOR signaling in the cell cycle progression of human prostate cancer
    • Gao N., Zhang Z., Jiang B.H., et al. Role of PI3K/AKT/mTOR signaling in the cell cycle progression of human prostate cancer. Biochem Biophys Res Commun 310 (2003) 1124-1132
    • (2003) Biochem Biophys Res Commun , vol.310 , pp. 1124-1132
    • Gao, N.1    Zhang, Z.2    Jiang, B.H.3
  • 30
    • 16244363070 scopus 로고    scopus 로고
    • Functions and regulation of transforming growth factor-beta (TGF-β) in the prostate
    • Danielpour D. Functions and regulation of transforming growth factor-beta (TGF-β) in the prostate. Eur J Cancer 41 (2005) 846-857
    • (2005) Eur J Cancer , vol.41 , pp. 846-857
    • Danielpour, D.1
  • 31
    • 0034533657 scopus 로고    scopus 로고
    • Signaling of transforming growth factor-β family members through SMAD proteins
    • Itoh S., Jtoh F., Goumans M.J., et al. Signaling of transforming growth factor-β family members through SMAD proteins. Eur J Biochem 267 (2000) 6954-6967
    • (2000) Eur J Biochem , vol.267 , pp. 6954-6967
    • Itoh, S.1    Jtoh, F.2    Goumans, M.J.3
  • 32
    • 0034604110 scopus 로고    scopus 로고
    • Role of transforming growth factor-β in human disease
    • Blobe G.C., Schiemann W.P., and Lodish H.F. Role of transforming growth factor-β in human disease. N Engl J Med 342 (2000) 1350-1358
    • (2000) N Engl J Med , vol.342 , pp. 1350-1358
    • Blobe, G.C.1    Schiemann, W.P.2    Lodish, H.F.3
  • 33
    • 0027421280 scopus 로고
    • Resistance to inhibition of cell growth by transforming growth factor-β and its role in oncogenesis
    • Fynan T.M., and Reiss M. Resistance to inhibition of cell growth by transforming growth factor-β and its role in oncogenesis. Crit Rev Oncog 4 (1993) 493-540
    • (1993) Crit Rev Oncog , vol.4 , pp. 493-540
    • Fynan, T.M.1    Reiss, M.2
  • 34
    • 0030183051 scopus 로고    scopus 로고
    • Tumor suppressor activity of the TGF-β pathway in human cancers
    • Markowitz S.D., and Roberts A.B. Tumor suppressor activity of the TGF-β pathway in human cancers. Cytokine Growth Factor Rev 7 (1996) 93-102
    • (1996) Cytokine Growth Factor Rev , vol.7 , pp. 93-102
    • Markowitz, S.D.1    Roberts, A.B.2
  • 35
    • 0037293657 scopus 로고    scopus 로고
    • Rapamycin induces Smad activity in prostate cancer cell lines
    • van der Poel H.G., Hanrahan C., Zhong H., et al. Rapamycin induces Smad activity in prostate cancer cell lines. Urol Res 30 (2003) 380-386
    • (2003) Urol Res , vol.30 , pp. 380-386
    • van der Poel, H.G.1    Hanrahan, C.2    Zhong, H.3
  • 36
    • 4544262684 scopus 로고    scopus 로고
    • Mammalian target of rapamycin and 3-phosphatidylinositol 3-kinase pathway inhibition enhances growth inhibition of transforming growth factor-β1 in prostate cancer cells
    • van der Poel H.G. Mammalian target of rapamycin and 3-phosphatidylinositol 3-kinase pathway inhibition enhances growth inhibition of transforming growth factor-β1 in prostate cancer cells. J Urol 172 4 Pt 1 (2004) 1333-1337
    • (2004) J Urol , vol.172 , Issue.4 PART 1 , pp. 1333-1337
    • van der Poel, H.G.1
  • 37
    • 34249779568 scopus 로고    scopus 로고
    • Temsirolimus, interferon α, or both for advanced renal-cell carcinoma
    • Hudes G., Carducci M., Tomczak P., et al. Temsirolimus, interferon α, or both for advanced renal-cell carcinoma. N Engl J Med 356 (2007) 2271-2281
    • (2007) N Engl J Med , vol.356 , pp. 2271-2281
    • Hudes, G.1    Carducci, M.2    Tomczak, P.3
  • 38
    • 34548528069 scopus 로고    scopus 로고
    • Phase I/II trial of temsirolimus combined with interferon α for advanced renal cell carcinoma
    • Motzer R.J., Hudes G.R., Curti B.D., et al. Phase I/II trial of temsirolimus combined with interferon α for advanced renal cell carcinoma. J Clin Oncol 25 (2007) 3958-3964
    • (2007) J Clin Oncol , vol.25 , pp. 3958-3964
    • Motzer, R.J.1    Hudes, G.R.2    Curti, B.D.3
  • 39
    • 1542398693 scopus 로고    scopus 로고
    • Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma
    • Atkins M.B., Hidalgo M., Stadler W.M., et al. Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma. J Clin Oncol 22 (2004) 909-918
    • (2004) J Clin Oncol , vol.22 , pp. 909-918
    • Atkins, M.B.1    Hidalgo, M.2    Stadler, W.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.